展望2019：寻求中国生物医药企业生存与发展的新平衡点

2018年是中国生物医药趋于理性发展的一年。2019年，在政策、经济环境的变化之下，制药企业将进入新的调整期。上海市药物研发协同创新中心召开智库圆桌会议，通过多轮头脑风暴，对我国生物医药行业进行了年度展望，提出生物医药企业需在生存与发展之间找到合适的新平衡点。

2019 Outlook: Find a New Balance between Survival and Development of China's Biopharmaceutical Industry

2018 witnessed the rational development of China's biopharmaceutical industry. In 2019, with the changes in political and economic environment, biopharmaceutical enterprises will enter a new period of adjustment. At the beginning of 2019, Shanghai Center for Innovation Drug Discovery and Development (SCIDDD) held a series of roundtable brainstorming, and proposed the 2019 outlook of China's biopharmaceutical industry, emphasizing that biopharmaceutical enterprises need to find a new balance between survival and development.